diabetic%20retinopathy
DIABETIC RETINOPATHY
Diabetic retinopathy is an abnormality of the microvasculature of the retina that occurs to almost all patients with chronic diabetes mellitus.
It is one of the leading cause of blindness worldwide and principal cause of impaired vision in patients aged 25-75 years of age.
The abnormality causes microaneurysms, retinal hemorrhages, lipid exudates, macular edema & neovascular vessel growth that may lead to blindness.

Follow Up

  • The follow-up interval recommended for the following DR severity:
    • 12 mths for normal or minimal NPDR
    • 6-12 mths for mild to moderate NPDR w/o CSME & inactive/involuted PDR w/o CSME
    • 2-4 mths for mild to moderate NPDR w/ CSME, severe NPDR, non-high-risk NPDR, high-risk NPDR & inactive/involuted PDR w/ CSME

Post-op Follow-up

  • A history of the changes on the following should be documented:
    • Symptoms
    • Glycemic status (HbA1c)
    • Systemic status (pregnancy, blood pressure, serum cholesterol, renal status)
  • Follow-up exam should include:
    • Visual acuity
    • Slit-lamp biomicroscopy w/ iris examination
    • Intraocular pressure (IOP) determination
    • Gonioscopy (if iris neovascularization is suspected or present or if IOP is increased)
    • Stereoscopic examination of the posterior pole after dilation of the pupils
    • Peripheral retina & vitreous examination, when indicated
Editor's Recommendations
Most Read Articles
Pearl Toh, Yesterday
First-line therapy with the BTK* inhibitor ibrutinib plus the anti-CD20 immunotherapy rituximab confers significant survival advantage over the current gold-standard regimen of fludarabine, cyclophosphamide, and rituximab (FCR) for young, fit patients with treatment-naïve chronic lymphocytic leukaemia (CLL), according to the E1912 trial, a large cooperative group study supported by the US National Cancer Institute.
6 days ago
Low-dose administrations of haloperidol after thoracic surgery does not appear to prevent postoperative delirium, according to a new study.
4 days ago
Percutaneous coronary intervention (PCI) displays comparable rates of mortality and serious composite outcomes but a higher rate of target-vessel revascularization at 10 years relative to coronary artery bypass grafting (CABG) in patients with significant left main coronary artery (LMCA) disease, reports a study. On the other hand, CABG delivers lower mortality and serious composite outcome rates compared with PCI with drug-eluting stents after 5 years.
Pearl Toh, 6 days ago
Apixaban slashes the risk of recurrent venous thromboembolism (VTE) by 90 percent in cancer patients compared with the low-molecular-weight heparin (LMWH) dalteparin, with no increase in major bleeding risk, according to the ADAM VTE study presented at ASH 2018.